Navigation Links
Researchers discover 'gateway' in nucleus has a second important job no one noticed before
Date:3/7/2013

UAlberta medical researchers and their American colleagues have discovered that the "gateway" known to control the movement of molecules in and out of a cell's nucleus appears to play another critically important role one no one had noticed until now.

These "gateways" have a second key job in a cell the ability to control the structure of chromosomes and the DNA linked to those chromosomes. This impacts what genes produce or express. The discovery gives scientists a new way to investigate the triggers for various kinds of disease, says Richard Wozniak, the principal investigator with the Faculty of Medicine & Dentistry, who worked on the discovery with collaborators from the Institute for Systems Biology (Seattle).

"This discovery may explain links between disease and defects in these gateways," he says.

"Our studies provide new insights into how the nucleus is organized and how the genetic material it houses is used, including important information about the jobs genes do. When cells have to adapt to their environment, they need to change their gene expressions pattern. If this isn't done right, diseases such as cancer or heart disease occur. Our work also provides insight into why many viral infections target this gateway for their survival."

The research team's discovery was recently published in the peer-reviewed journal, Cell.

Wozniak and his team are continuing their research in this area. They want to learn more about this new mechanism when it functions properly, and what causes it to malfunction. Uncovering the key players in this new mechanism are also key, he says.

"We want to understand how these gateways are functioning at a molecular level what makes them capable of altering the structure of chromosomes and making other key changes? That is our next step," says Wozniak, who is a researcher with the Department of Cell Biology.


'/>"/>

Contact: Raquel Maurier
raquel.maurier@ualberta.ca
780-492-5986
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Page: 1

Related biology news :

1. Researchers explain a key developmental mechanism for the first time in plants
2. Researchers find molecular switch turning on self-renewal of liver damage
3. UGA researchers shed light on ancient origin of life
4. Researchers discover workings of brains GPS system
5. Researchers propose new solution to ensure biofuel plants dont become noxious weeds
6. Temple researchers discover key to heart failure, new therapies on horizon
7. Researchers discover gene that causes obesity in mice
8. U of M researchers utilize genetically corrected stem cells to spark muscle regeneration
9. Researchers id queens, mysterious disease syndrome as key factors in bee colony deaths
10. Study led by NUS researchers proves the existence of 3 overstretched DNA structures
11. U of M researchers identify genetic variation behind acute myeloid leukemia treatment success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... 2015  It is gratifying to see that the ... genomic science as a means to better understand human ... I was honored to participate in today,s White House ... Since the 1980s my teams have ... first sequenced genome of a free living organism, the ...
(Date:1/22/2015)... Jan. 13, 2015  Today, FreeWavz ( www.FreeWavz.com ), ... crowdfunding campaign on Fundable, https://www.fundable.com/freewavz . FreeWavz ... production capacity to meet customer demand. ... http://photos.prnewswire.com/prnh/20150113/168790 Invented by ...
(Date:1/22/2015)... and POINT ROBERTS, Washington , January 20, ... leading sectors including technology and tech stocks, releases video from ... master pickpocket and security consultant Apollo Robbins . ... talks about the Wocket™ biometric smart wallet, a product of ...
Breaking Biology News(10 mins):J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
... Israel The Israeli Chairmanship of EUREKA, the largest pan-European ... new data from a report conducted by Kalman Gayer ... Ltd., to mark the completion of Israel,s Chairmanship year ... proven impact of EUREKA on companies participating in EUREKA ...
... This release is available in German . ... congenital deaf-blindness in humans and affects 1 in 6,000 of ... both clinically and genetically heterogeneous. In the most severe cases, ... degeneration of the retina in puberty, ultimately resulting in complete ...
... are the most abundant parasites on Earth. Well known viruses, ... such as the tobacco mosaic virus infect plant hosts. ... bacteria known as bacteriophages, or phages. In part, this is ... have been cut off from their usual biological surroundings in ...
Cached Biology News:Is governmental investment in industrial R&D paying off? 2Is governmental investment in industrial R&D paying off? 3Treatment approach to human Usher syndrome: Small molecules ignore stop signals 2Treatment approach to human Usher syndrome: Small molecules ignore stop signals 3When viruses infect bacteria 2
(Date:3/2/2015)... 2, 2015 Cutting-edge biotech ... food nutrition products reveal technological advancements are in ... such as hyperglycemia, obesity, insulin level issues and ... Biotech Companies in focus today are: RiceBran Technologies (NASDAQ: ... (NYSE: ANFI ), CEL-SCI Corporation (NYSE: ...
(Date:3/2/2015)... , March 2, 2015 VG ... developing therapies for autoimmune and infectious diseases, announced ... has issued an important new composition of matter ... through the targeting of CLIP. ... technology underlying VG Life Sciences, VG1177, a synthetic ...
(Date:3/2/2015)... Outside GC, the leading provider of on-demand, in-house ... Casey as a member of the firm, further strengthening ... , Debbie has spent over 20 years in the ... North America in both legal and business capacities. ... Outside GC’s growing list of healthcare clients, with a ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Immunovaccine Inc. ... aware of a fraudulent press release disseminated this morning ... be from Immunovaccine. This press release states that Immunovaccine ... Inc. The press release did not originate from ... contained within the press release. Please note that ...
Breaking Biology Technology:Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Outside GC Expands Healthcare Team 2Immunovaccine Disclaims Hoax Press Release 2
... Inc. (NYSE Amex: PTN ) today announced ... a strategic reassessment of its research and development activities ... resources and efforts on clinical trials of bremelanotide for ... severe asthma. In implementing this plan, Palatin is reducing ...
... DIEGO, Sept. 24 Cylene Pharmaceuticals, Inc. announced ... trial of their first-in-class, oral CK2 inhibitor CX-4945 ... the simultaneous closing of a $12 million financing ... HBM BioVentures (Cayman) Ltd., Novartis BioVenture Fund, BioVentures ...
... PHILADELPHIA, BOONTON, N.J. and BRUSSELS, Sept. 24 ... Bulletin Board: UGNE ) today reported ... effects in combination with other drugs in reducing ... are being presented at the 2010 Osteoarthritis Research ...
Cached Biology Technology:Palatin Announces Strategic Realignment of Operations 2Palatin Announces Strategic Realignment of Operations 3Palatin Announces Strategic Realignment of Operations 4Palatin Announces Strategic Realignment of Operations 5Cylene Initiates Phase I Trial in Multiple Myeloma With CX-4945 Inhibitor of CK2 and Closes Accompanying Financing 2Cylene Initiates Phase I Trial in Multiple Myeloma With CX-4945 Inhibitor of CK2 and Closes Accompanying Financing 3Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis 2Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis 3Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis 4Tarsa Therapeutics and Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility in Combination Therapy for the Treatment of Osteoarthritis 5
...
Homo sapiens similar to Cytosolic acyl coenzyme A thioester hydrolase Antigen: Peptide...
Borrelia Burgdorfen (IgG) -Ab EIA Sample Size: 100 l...
96 Well Base Plate...
Biology Products: